Ameriprise’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-42,951
Closed -$267K 3969
2022
Q4
$267K Buy
42,951
+12
+0% +$86 ﹤0.01% 3624
2022
Q3
$287K Sell
42,939
-1,970
-4% -$13.5K ﹤0.01% 3596
2022
Q2
$286K Buy
44,909
+26,510
+144% +$150K ﹤0.01% 3574
2022
Q1
$86K Sell
18,399
-94,245
-84% -$404K ﹤0.01% 3854
2021
Q4
$564K Buy
+112,644
New +$902K ﹤0.01% 3477
2020
Q2
Sell
-5,983
Closed -$327K 3694
2020
Q1
$327K Buy
+5,983
New +$316K ﹤0.01% 3279
2019
Q3
Sell
-25,640
Closed -$1.19M 3719
2019
Q2
$1.19M Buy
25,640
+145
+0.6% +$6.81K ﹤0.01% 2990
2019
Q1
$1.02M Sell
25,495
-70
-0.3% -$3.14K ﹤0.01% 3033
2018
Q4
$1.18M Buy
25,565
+16,400
+179% +$790K ﹤0.01% 2882
2018
Q3
$406K Buy
+9,165
New +$421K ﹤0.01% 3356
2018
Q2
Sell
-21,472
Closed -$1.55M 3655
2018
Q1
$1.55M Sell
21,472
-3,762
-15% -$276K ﹤0.01% 2787
2017
Q4
$1.66M Buy
25,234
+321
+1% +$17.3K ﹤0.01% 2750
2017
Q3
$1.25M Sell
24,913
-9,368
-27% -$452K ﹤0.01% 2866
2017
Q2
$1.59M Sell
34,281
-8,110
-19% -$298K ﹤0.01% 2722
2017
Q1
$1.5M Buy
+42,391
New +$971K ﹤0.01% 2709
2015
Q2
Sell
-17,587
Closed -$1.63M 4036
2015
Q1
$1.63M Sell
17,587
-22,061
-56% -$1.42M ﹤0.01% 2683
2014
Q4
$1.6M Buy
+39,648
New +$1.21M ﹤0.01% 2650

Other funds holding ESPR